EUVIMEDEUVIMED entdecken
Open Access

Safety and Efficacy of Gadobutrol-enhanced Mri in Patients Aged under 2 Years–-a Single-center, Observational Study

Ravi Bhargava, Michelle Noga

Magnetic Resonance Insights · 2013

DOI: 10.4137/mri.s10996 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Magnetic Resonance Insights, 2013. Verfasst von Ravi Bhargava und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Diagnostic Imaging, Stollery Children's Hospital, University of Alberta, Edmonton, Alberta, Canada. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gadobutrol is a 1-molar gadolinium-based contrast agent with well-characterized safety and efficacy for magnetic resonance imaging (MRI) in adults and children ≥ 2 years old. This observational study assessed gadobutrol-enhanced MRI in children < 2 years of age. Sixty infants (mean age 11.1 months) underwent MRI using gadobutrol at standard dose of 0.1 mL/kg (0.1 mmol/kg) body weight. MRI examinations included brain, spine, and neck (n = 24), subcutaneous soft tissues (n = 14), chest, abdomen, and pelvis (n = 12), musculoskeletal system (n = 7) and vascular system (n = 3). No patients experienced adverse events related to gadobutrol injection. In 57 patients with confirmed diagnoses, gadobutrol-enhanced MRI provided findings consistent with confirmed pathologies. This study indicates that gadobutrol at a standard dose for MRI is safe in patients aged < 2 years and provides diagnostic information for multiple pathologies.

Schlagwörter

Stichwörter der Autor:innen

contrast mediagadobutrolgadoliniumpediatric MRI

Autor:innen und Institutionen

  • Department of Radiology and Diagnostic Imaging, Stollery Children's Hospital, University of Alberta, Edmonton, Alberta, Canada.

Zitieren

APA

Bhargava, R., & Noga, M. (2013). Safety and Efficacy of Gadobutrol-enhanced Mri in Patients Aged under 2 Years–-a Single-center, Observational Study. Magnetic Resonance Insights. https://doi.org/10.4137/mri.s10996

Vancouver

Bhargava R, Noga M. Safety and Efficacy of Gadobutrol-enhanced Mri in Patients Aged under 2 Years–-a Single-center, Observational Study. Magnetic Resonance Insights. 2013. doi:10.4137/mri.s10996

BibTeX
@article{Bhargava2013,
  author = {Bhargava, Ravi and Noga, Michelle},
  title = {Safety and Efficacy of Gadobutrol-enhanced Mri in Patients Aged under 2 Years–-a Single-center, Observational Study},
  journal = {Magnetic Resonance Insights},
  year = {2013},
  doi = {10.4137/mri.s10996}
}
Kostenlos starten →